163
Participants
Start Date
October 31, 2006
Primary Completion Date
July 31, 2008
Study Completion Date
July 31, 2008
Probuphine
4 implants
placebo
4 implants
New York VA Medical Center, NYU School of Medicine, New York
Addiction Institute of New York, New York
University of Pennsylvania Treatment Research Center, Philadelphia
Behavioral Biology Research Unit, Johns Hopkins Bayview Campus, Baltimore
Duke University Medical Center Addictions Program, Durham
Northwest Behavioral Research Center, Roswell
Amit Vijapura, MD and Associates, Jacksonville
Scientific Clinical Research, Inc, North Miami
Fidelity Clinical Research, Lauderhill
Wayne State University Department of Psychiatry and Behavioral Neurosciences, Detroit
Psych Care Consultants Research, St Louis
Pahl Pharmaceutical Research, LLC, Oklahoma City
David Geffen School of Medicine at UCLA, Los Angeles
Synergy Clinical Research Center, National City
North County Clinical Research, Oceanside
Puget Sound Health Care Systems, Seattle
Providence Behavioral Health Services, Everett
Dual Diagnosis Unit, SSTAR: Stanley Street Treatment and Resources, Inc., Fall River
Lead Sponsor
Titan Pharmaceuticals
INDUSTRY